BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 18412252)

  • 1. Spectrum of gait impairments in presymptomatic and symptomatic Huntington's disease.
    Rao AK; Muratori L; Louis ED; Moskowitz CB; Marder KS
    Mov Disord; 2008 Jun; 23(8):1100-7. PubMed ID: 18412252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practical use of the nursing code of ethics: part I.
    Lachman VD
    Medsurg Nurs; 2009; 18(1):55-7. PubMed ID: 19331301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data.
    Tabrizi SJ; Langbehn DR; Leavitt BR; Roos RA; Durr A; Craufurd D; Kennard C; Hicks SL; Fox NC; Scahill RI; Borowsky B; Tobin AJ; Rosas HD; Johnson H; Reilmann R; Landwehrmeyer B; Stout JC;
    Lancet Neurol; 2009 Sep; 8(9):791-801. PubMed ID: 19646924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene-dosage- and sex-dependent differences in the prodromal-Like phase of the F344tgHD rat model for Huntington disease.
    Ratz-Wirsching V; Habermeyer J; Moceri S; Harrer J; Schmitz C; von Hörsten S
    Front Neurosci; 2024; 18():1354977. PubMed ID: 38384482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurophysiology of cerebellar ataxias and gait disorders.
    Manto M; Serrao M; Filippo Castiglia S; Timmann D; Tzvi-Minker E; Pan MK; Kuo SH; Ugawa Y
    Clin Neurophysiol Pract; 2023; 8():143-160. PubMed ID: 37593693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spatiotemporal Gait Parameters in Adults With Premanifest and Manifest Huntington's Disease: A Systematic Review.
    Browning S; Holland S; Wellwood I; Bilney B
    J Mov Disord; 2023 Sep; 16(3):307-320. PubMed ID: 37558234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gait Variability to Phenotype Common Orthopedic Gait Impairments Using Wearable Sensors.
    Kushioka J; Sun R; Zhang W; Muaremi A; Leutheuser H; Odonkor CA; Smuck M
    Sensors (Basel); 2022 Nov; 22(23):. PubMed ID: 36502003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digital Phenotyping in Clinical Neurology.
    Gupta AS
    Semin Neurol; 2022 Feb; 42(1):48-59. PubMed ID: 35016250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of Daily-Living Gait Quantity and Quality Using a Wrist-Worn Accelerometer in Huntington's Disease.
    Keren K; Busse M; Fritz NE; Muratori LM; Gazit E; Hillel I; Scheinowitz M; Gurevich T; Inbar N; Omer N; Hausdorff JM; Quinn L
    Front Neurol; 2021; 12():719442. PubMed ID: 34777196
    [No Abstract]   [Full Text] [Related]  

  • 10. Approach to Posture and Gait in Huntington's Disease.
    Talman LS; Hiller AL
    Front Bioeng Biotechnol; 2021; 9():668699. PubMed ID: 34386484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lower limb kinematic, kinetic, and EMG data from young healthy humans during walking at controlled speeds.
    Moreira L; Figueiredo J; Fonseca P; Vilas-Boas JP; Santos CP
    Sci Data; 2021 Apr; 8(1):103. PubMed ID: 33846357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Backward Walking and Dual-Task Assessment Improve Identification of Gait Impairments and Fall Risk in Individuals with MS.
    Edwards EM; Kegelmeyer DA; Kloos AD; Nitta M; Raza D; Nichols-Larsen DS; Fritz NE
    Mult Scler Int; 2020; 2020():6707414. PubMed ID: 32963832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The trajectory of gait development in mice.
    Akula SK; McCullough KB; Weichselbaum C; Dougherty JD; Maloney SE
    Brain Behav; 2020 Jun; 10(6):e01636. PubMed ID: 32333523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gait variability as digital biomarker of disease severity in Huntington's disease.
    Gaßner H; Jensen D; Marxreiter F; Kletsch A; Bohlen S; Schubert R; Muratori LM; Eskofier B; Klucken J; Winkler J; Reilmann R; Kohl Z
    J Neurol; 2020 Jun; 267(6):1594-1601. PubMed ID: 32048014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of dual-task cognitive interference on gait and turning in Huntington's disease.
    Purcell NL; Goldman JG; Ouyang B; Liu Y; Bernard B; O'Keefe JA
    PLoS One; 2020; 15(1):e0226827. PubMed ID: 31910203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. International Guidelines for the Treatment of Huntington's Disease.
    Bachoud-Lévi AC; Ferreira J; Massart R; Youssov K; Rosser A; Busse M; Craufurd D; Reilmann R; De Michele G; Rae D; Squitieri F; Seppi K; Perrine C; Scherer-Gagou C; Audrey O; Verny C; Burgunder JM
    Front Neurol; 2019; 10():710. PubMed ID: 31333565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effects of Dual-Task Cognitive Interference and Environmental Challenges on Balance in Huntington's Disease.
    Purcell NL; Goldman JG; Ouyang B; Bernard B; O'Keefe JA
    Mov Disord Clin Pract; 2019 Mar; 6(3):202-212. PubMed ID: 30949551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The "Stutter-Step": A Peculiar Gait Feature in Advanced Huntington's Disease and Chorea-Acanthocytosis.
    Termsarasab P; Frucht SJ
    Mov Disord Clin Pract; 2018; 5(2):223-224. PubMed ID: 30746406
    [No Abstract]   [Full Text] [Related]  

  • 19. Regional gray matter abnormality in hepatic myelopathy patients after transjugular intrahepatic portosystemic shunt: a voxel-based morphometry study.
    Liu K; Chen G; Ren SY; Zhu YQ; Yu TL; Tian P; Li C; Xi YB; Wang ZY; Ye JJ; Han GH; Yin H
    Neural Regen Res; 2019 May; 14(5):850-857. PubMed ID: 30688271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supplementary motor area connectivity and dual-task walking variability in multiple sclerosis.
    Fritz NE; Kloos AD; Kegelmeyer DA; Kaur P; Nichols-Larsen DS
    J Neurol Sci; 2019 Jan; 396():159-164. PubMed ID: 30472552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.